advanced lung carcinoma
Showing 1 - 9 of 9
Advanced Lung Carcinoma Trial in Beijing (LK101 injection (personlized neoantigen pulsed DC vaccine ), Pembrolizumab,
Recruiting
- Advanced Lung Carcinoma
- LK101 injection (personlized neoantigen pulsed DC vaccine )
- +2 more
-
Beijing, Beijing, ChinaCancer hospital Chinese Academy of Medical Sciences
May 23, 2023
Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)
Recruiting
- Triple Negative Breast Cancer
- +14 more
- LYL797
-
Scottsdale, Arizona
- +10 more
Jan 30, 2023
Advanced Lung Carcinoma, Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte (Psychosocial
Active, not recruiting
- Advanced Lung Carcinoma
- +6 more
- Psychosocial Care Conquer Fear Support intervention (psychoeducation, attention training, worry management, and detached mindfulness components)
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Advanced Lung Carcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Jacksonville (Best Practice,
Recruiting
- Advanced Lung Carcinoma
- +2 more
- Best Practice
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 6, 2022
Advanced Lung Carcinoma, Metastatic Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte
Active, not recruiting
- Advanced Lung Carcinoma
- +8 more
- Educational Intervention
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 3, 2022
Advanced Lung Carcinoma, Metastatic Lung Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Columbus (Behavioral, Psychological or
Recruiting
- Advanced Lung Carcinoma
- +4 more
- Behavioral, Psychological or Informational Intervention
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal
Recruiting
- Advanced Lung Carcinoma
- +16 more
- Anti-CTLA4 Monoclonal Antibody BMS-986218
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2022
Advanced Lung Carcinoma Trial in China (TQB3616 capsules, Anlotinib Hydrochloride capsules, Irinotecan Hydrochloride for
Recruiting
- Advanced Lung Carcinoma
- TQB3616 capsules
- +2 more
-
Chongqing, Chongqing, China
- +6 more
Sep 18, 2021
Advanced Lung Carcinoma, NSCLC Trial (Anti-PD-1/PD-L1 Monoclonal Antibody,Chemotherapy, Bronchoscopy-assisted Interventional
Not yet recruiting
- Advanced Lung Carcinoma
- Non-small Cell Lung Cancer
- Anti-PD-1/PD-L1 Monoclonal Antibody,Chemotherapy
- Bronchoscopy-assisted Interventional Therapy
- (no location specified)
Jan 7, 2021